For nearly two decades, Medicare drug coverage carried a notorious trap: the “donut hole,” a mid-year coverage gap that left many older Americans suddenly paying far more for the same prescriptions once their spending crossed a threshold. That gap is now gone. A hard annual cap on out-of-pocket drug costs has replaced it, so the seasonal spike that used to blindside retirees in the summer or fall no longer exists, and no one on Part D can be billed past a fixed yearly ceiling again.
How the donut hole punished retirees mid-year
The coverage gap worked like a cruel intermission. A Part D enrollee paid predictable copays early in the year, but once total drug spending, the enrollee’s share plus the plan’s, reached a set limit, the plan pulled back its contribution and the beneficiary’s costs jumped for a stretch until catastrophic coverage finally kicked in. Someone on expensive medication could sail through spring, then hit the gap and watch a monthly prescription bill balloon overnight through no change in their prescriptions.
That structure hit the sickest people hardest, precisely because heavy medication users reached the gap fastest. Retirees on multiple brand-name drugs often crossed into the donut hole by mid-year and faced hundreds or thousands of dollars in higher costs before catastrophic coverage relieved them. The timing was unpredictable enough that many people simply stopped filling prescriptions when the gap hit, a rationing behavior the design all but invited.
Free retirement updates: One number can cost or save hundreds a month in retirement. The free Retirement Shield newsletter surfaces the ones worth knowing. Sign up free.
The hard cap that replaced it
The Inflation Reduction Act closed the gap and installed something Part D never had before: a firm annual ceiling on what an enrollee pays out of pocket for covered drugs. Beginning in 2025, the costs for Medicare drug coverage follow a simpler path, a deductible phase, then a phase where the enrollee pays copays or coinsurance, and once out-of-pocket spending reaches the annual cap, the enrollee pays nothing more for covered medications for the rest of the year.
The cap itself is indexed to rise modestly over time. It was set at $2,000 for 2025 and increases to $2,100 for the 2026 plan year, as consumer guidance on the change explains. The number matters less than the principle: for the first time, a Part D enrollee has a known, guaranteed maximum, and the mid-year cost explosion that defined the donut hole has been engineered out of the program entirely.
Why costs no longer spike partway through the year
Under the old design, hitting a threshold made drugs more expensive; under the new one, hitting the threshold makes them free. That reversal is the heart of why the seasonal spike has vanished. Instead of a gap that raised a retiree’s share in the middle of the year, spending now moves steadily toward a single ceiling, after which the cost drops to zero. There is no longer a window where the same prescription suddenly costs several times more than it did the month before.
For a retiree on high-cost medication, the difference is measured in real money and real predictability. A person whose annual drug costs once ran well past the old gap into five figures now stops paying after reaching the cap, and can plan a year’s medication budget around a fixed number rather than bracing for an unpredictable mid-year surge. The change is permanent under current law, applying to every standard Part D and Medicare Advantage drug plan.
Spreading the cap across the year
One wrinkle remains worth understanding. Because the cap can still be reached early for someone with very expensive drugs, the out-of-pocket cost could otherwise land in a lump early in the year. To smooth that, the same law created the Medicare Prescription Payment Plan, which lets enrollees spread their out-of-pocket drug costs into monthly installments across the calendar year instead of paying large sums at the pharmacy counter up front.
The Medicare Prescription Payment Plan does not lower the total a person owes; it only changes the timing, converting the annual cap into predictable monthly payments. That helps retirees on fixed incomes who might otherwise struggle to cover a large charge in January or February, and it pairs with the cap to make drug costs both bounded and evenly paced for the first time in the program’s history.
Taken together, the elimination of the donut hole and the arrival of a hard annual cap rank among the most consequential changes to Medicare in years, especially for the retirees who take the most medication. The trap that once forced people to ration pills in the second half of the year is gone, replaced by a ceiling that turns the worst-case drug year into a known, fixed, and ultimately capped expense.
This article was researched and drafted with the assistance of AI and reviewed by The Money Overview editorial team.
More Financial Reading
